Julia Haller appointed as new CEO of Wills Eye Hospital in Philadelphia, taking over from Joe Bilson.

Wills Eye Hospital has appointed Julia Haller as its new ophthalmologist-in-chief, taking over the role previously held by Joseph P. Bilson, who served as CEO since 2007. This leadership transition was officially announced this week, marking a significant change for the nonprofit specialty hospital located in Center City, Philadelphia.

Haller, who has been a part of Wills Eye since 2007, continues to fulfill her clinical responsibilities while assuming her new executive position. In addition to her role at Wills, she is also a professor and chair of ophthalmology at Thomas Jefferson University’s Sidney Kimmel Medical College. She officially began her tenure as CEO on Friday, stepping into a prominent leadership role at a recognized institution in the field of ophthalmology.

Wills Eye Hospital has deep historical roots dating back to 1832, originating from a bequest made to the city of Philadelphia by Quaker merchant James Wills. The current governance of Wills Eye falls under the management of the Board of Directors of City Trusts, established in 1869 to ensure the independent management of such philanthropic gifts intended for the city.

Michael A. Nutter, former mayor of Philadelphia and current president of the City Trusts Board, expressed confidence in Haller’s capabilities, describing her as a trailblazing retina surgeon and internationally recognized ophthalmologist. Nutter stated that under her leadership, Wills Eye is poised for a promising future.

Haller succeeds Bilson, who announced his retirement earlier this year. During Bilson’s tenure, Wills Eye experienced various operational challenges, culminating in its latest financial report, which revealed a .5 million operating loss on revenues of 1.8 million for the fiscal year ending June 30, 2023. This recent loss follows two prior years where the institution recorded operating losses nearing million each year.

As Wills Eye moves forward, Haller’s leadership is crucial in addressing these financial challenges while continuing to provide high-quality ophthalmic care. The hospital, recognized for its innovation and specialized services, looks to build on its legacy as it enters a new chapter under Haller’s guidance.